Zobrazeno 1 - 10
of 265
pro vyhledávání: '"J Chanard"'
Publikováno v:
Biomaterials. 29:1139-1146
The combination of negatively-charged membranes and angiotensin I-converting enzyme inhibitors (ACEi) evokes hypersensitivity reactions (HSR) during hemodialysis and bradykinin (BK)-related peptides have been hypothesized as being responsible for the
Autor:
P. Simon, S. Lavaud, Q.L. Duan, Yves Lepage, Giuseppe Molinaro, Albert Adam, Marie Eve Moreau, Guy Boileau, P. Clavel, Guy A. Rouleau, Miguel Chagnon, J. Chanard
Publikováno v:
Kidney International. 70:1823-1831
Although the association of angiotensin I-converting enzyme inhibitors (ACEis) with a negatively charged membrane is thought to be responsible for hypersensitivity reactions (HSRs) during hemodialysis, we hypothesize that these complications are due
Autor:
Guy A. Rouleau, Nancy J. Brown, Angelo Agostoni, Jacky Potier, Giuseppe Molinaro, J Chanard, Jean L. Rouleau, James V. Gainer, Leah Flury, Bassem Wehbe, Qing Ling Duan, Julien Marc-Aurèle, Marie-Pierre Dubé, Albert Adam, Patrick A. Dion, Daniel Rochefort, Inge A. Meijer, Pierre Clavel, Tatiana Foroud, Massimo Cugno, Seddik Benarbia, Pierre Simon, Borzoo Nikpoor, Judith Saint-Onge
Publikováno v:
The American Journal of Human Genetics. 77(4):617-626
Angiotensin I–converting enzyme inhibitors (ACEi), which are used to treat common cardiovascular diseases, are associated with a potentially life-threatening adverse reaction known as angioedema (AE-ACEi). We have previously documented a significan
Publikováno v:
Nephrology Dialysis Transplantation. 18:252-257
Autor:
J Chanard
Publikováno v:
Réanimation Urgences. 7:183-188
Autor:
Eric Canivet, H Wampach, Olivier Toupance, Jean-Claude Liehn, S Lavaud, B. Lardennois, J Chanard, B. Brandt
Publikováno v:
Nephrology Dialysis Transplantation. 12:67-70
Background. The activity in the renin angiotensin system is important for the progression of diabetic nephropathy. Genetic abnormalities in this system have been suggested as a risk factor for the development and progression of diabetic nephropathy.
Autor:
F. Mignon, Michel Godin, D. Durand, N. El Esper, T. Hannedouche, J.-M. Suc, P. Landais, Jean-Pierre Grünfeld, B. Goldfarb, J. Chanard, A. Fournier
Publikováno v:
BMJ. 309:833-837
Objective: To compare the ability of angiotensin converting enzyme inhibitors and β blockers to slow the development of end stage renal failure in non-diabetic patients with chronic renal failure. Design: Open randomised multicentre trial with three
Publikováno v:
American Journal of Kidney Diseases. 23:41-46
Cytokine synthesis and secretion by blood mononuclear cells is a well-documented phenomenon in hemodialyzed patients. The present study was conducted in 17 chronically hemodialyzed patients to test the relative effect of uremic toxicity, membrane bio